2013European Journal of Hospital PharmacyRequires access

EMA approved new drugs: Photodynamic therapy for actinic keratosis

Mark Nolan

Open publisher page 1 citations

Abstract

Actinic keratoses are superficial neoplasms that develop from sun-damaged skin and, if not treated, may progress to cutaneous squamous cell carcinoma. They tend to appear on the face, scalp, back of the hands, chest or other sun-exposed areas and often appear as flat, scaly, red or pink areas that may be easier to feel than see. According to Cancer Research UK, almost 100 000 cases of non-melanoma skin cancer are diagnosed in the UK each year. This makes it the most common type of cancer by far. This type of cancer also tends to be under-reported. Treatment typically consists of liquid nitrogen cryotherapy, surgical removal, topical 5-fluorouracil, imiquimod, ingenol mebutate, topical diclofenac, retinoids, dermabrasion, chemical peels and/or photodynamic therapy (PDT). Deciding which treatment to choose depends on the size, location and number of lesions. For most cases the inexpensive remedy of liquid nitrogen is the treatment of choice, while those …

About this research paper

What this paper is about

Actinic keratoses are superficial neoplasms that develop from sun-damaged skin and, if not treated, may progress to cutaneous squamous cell carcinoma. They tend to appear on the face, scalp, back of the hands, chest or other sun-exposed areas and often appear as flat, scaly, red or pink areas that may be easier to feel than see. According to Cancer Research UK, almost 100 000 cases of non-melanoma skin cancer are diagnosed in the UK each year. This makes it the most common type of cancer by far. This type of cancer also tends to be under-reported. Treatment typically consists of liquid nitrogen cryotherapy, surgical removal, topical 5-fluorouracil, imiquimod, ingenol mebutate, topical diclofenac, retinoids, dermabrasion, chemical peels and/or photodynamic therapy (PDT). Deciding which treatment to choose depends on the size, location and number of lesions. For most cases the inexpensive remedy of liquid nitrogen is the treatment of choice, while those …

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Actinic keratoses are superficial neoplasms that develop from sun-damaged skin and, if not treated, may progress to cutaneous squamous cell carcinoma. They tend to appear on the face, scalp, back of the hands, chest or other sun-exposed areas and often appear as flat, scaly, red or pink areas that may be easier to feel than see. According to Cancer Research UK, almost 100 000 cases of non-melanoma skin cancer are diagnosed in the UK each year. This makes it the most common type of cancer by far. This type of cancer also tends to be under-reported. Treatment typically consists of liquid nitrogen cryotherapy, surgical removal, topical 5-fluorouracil, imiquimod, ingenol mebutate, topical diclofenac, retinoids, dermabrasion, chemical peels and/or photodynamic therapy (PDT). Deciding which treatment to choose depends on the size, location and number of lesions. For most cases the inexpensive remedy of liquid nitrogen is the treatment of choice, while those …

Key concepts: Actinic keratosis, Imiquimod, Dermatology, Medicine, Actinic keratoses, Dermabrasion, Cryotherapy, Photodynamic therapy

Related papers

Back to paper searchBrowse research topicsOriginal source
EMA approved new drugs: Photodynamic therapy for actinic keratosis — Research Paper | ScholarLens